{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:26:06Z","timestamp":1777332366908,"version":"3.51.4"},"reference-count":26,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,6,15]]},"DOI":"10.2169\/internalmedicine.2059-18","type":"journal-article","created":{"date-parts":[[2019,2,24]],"date-time":"2019-02-24T22:34:02Z","timestamp":1551047642000},"page":"1791-1794","source":"Crossref","is-referenced-by-count":13,"title":["Duloxetine and Angiotensin II Receptor Blocker Combination Potentially Induce Severe Hyponatremia in an Elderly Woman"],"prefix":"10.2169","volume":"58","author":[{"given":"Atsushi","family":"Takayama","sequence":"first","affiliation":[{"name":"Department of Family Medicine, Iwakuni Municipal Miwa Hospital, Japan"},{"name":"Jichi Medical University Center for Community Medicine, Division of Community and Family Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Nagamine","sequence":"additional","affiliation":[{"name":"Sunlight Brain Research Center, Japan"},{"name":"Department of Emergency Medicine, Matsumoto Surgical Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Matsumoto Surgical Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Howard SS, Eric JS, Benjamin RS. Duloxetine in the management of chronic musculoskeletal pain Smith. Ther Clin Risk Manag 8: 267-277, 2012.","DOI":"10.2147\/TCRM.S17428"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gahimer J, Wernicke J, Yalcin I, Ossanna MJ, Wulster-Radcliffe M, Viktrup L. A retrospective pooled analysis of duloxetine safety in 23,983 subjects. Curr Med Res Opin 23: 175-184, 2007.","DOI":"10.1185\/030079906X162719"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nagamine T. Responsibility of the doctor who prescribes serotonin and noradrenaline reuptake inhibitors for patients with chronic musculoskeletal pain. Psychiatry Clin Neurosci 72: 45-46, 2018.","DOI":"10.1111\/pcn.12612"},{"key":"4","unstructured":"4. Esposito P, Piotti G, Bianzina S, Malul Y, Dal Canton A. The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new therapeutic options. Nephron Clin Pract 119: c62-c73, 2011."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Adrogu\u00e9 HJ, Madias NE. Hyponatremia. N Engl J Med 343: 886-887, 2000.","DOI":"10.1056\/NEJM200009213431212"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Miller M, Hecker MS, Friedlander DA, Carter JM. Apparent idiopathic hyponatremia in an ambulatory geriatric population. J Am Geriatr Soc 44: 404-408, 1996.","DOI":"10.1111\/j.1532-5415.1996.tb06410.x"},{"key":"7","unstructured":"7. Kirby D, Harrigan S, Ames D. Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit. Int J Geriatr Psychiatry 17: 231-237, 2002."},{"key":"8","unstructured":"8. Revol R, Rault C, Polard E, Bellet F, Guy C. Hyponatremia associated with SSRI\/NRSI: Descriptive and comparative epidemiological study of the incidence rates of the notified cases from the data of the French National Pharmacovigilance Database and the French National Health Insurance. Encephale 44: 291-296, 2018."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Iovino M, Steardo L. Effect of substances influencing brain serotonergic transmission on plasma vasopressin levels in the rat. Eur J Pharmacol 113: 99-103, 1985.","DOI":"10.1016\/0014-2999(85)90347-4"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kulkarni M. Duloxetine induced hyponatremia. Indian J Nephrol 25: 259, 2015.","DOI":"10.4103\/0971-4065.151352"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nakamura M, Satoh Y, Hiraoka A, Fujita Y, Nagamine T. Duloxetine-induced hyponatremia in the elderly. Clin Neuropsychopharmacol Ther 3: 33-36, 2012.","DOI":"10.5234\/cnpt.3.33"},{"key":"12","unstructured":"12. Amoako AO, Brown C, Riley T. Syndrome of inappropriate antidiuretic hormone secretion: a story of duloxetine-induced hyponatraemia. BMJ Case Rep 2015: 208037, 2015."},{"key":"13","unstructured":"13. Siegel AJ, Forte SS, Bhatti NA, Gelda SE. Drug-related hyponatremic encephalopathy: rapid clinical response averts life-threatening acute cerebral edema. Am J Case Rep 17: 150-153, 2016."},{"key":"14","unstructured":"14. Alev L, Fujikoshi S, Yoshikawa A, et al. Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials. J Pain Res 10: 1723-1731, 2017."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Gao Y, Stuart D, Pollock JS, Takahishi T, Kohan DE. Collecting duct-specific knockout of nitric oxide synthase 3 impairs water excretion in a sex-dependent manner. Am J Physiol Renal Physiol 311: F1074-F1083, 2016.","DOI":"10.1152\/ajprenal.00494.2016"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Correia L, Ferreira R, Correia I, et al. Severe hyponatremia in older patients at admission in an internal medicine department. Arch Gerontol Geriatr 59: 642-647, 2014.","DOI":"10.1016\/j.archger.2014.08.002"},{"key":"17","unstructured":"17. Hilliard LM, Mirabito KM, Denton KM. Unmasking the potential of the angiotensin AT2 receptor as a therapeutic target in hypertension in men and women: what we know and what we still need to find out. Clin Exp Pharmacol Physiol 40: 542-550, 2013."},{"key":"18","unstructured":"18. Knadler MP, Lobo E, Chappell J, Bergstrom R. Duloxetine: clinical pharmacokinetics and drug interactions. Clin Pharmacokinet 50: 281-294, 2011."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wernicke JF, Gahimer J, Yalcin I, Wulster-Radcliffe M, Viktrup L. Safety and adverse event profile of duloxetine. Expert Opin Drug Saf 4: 987-993, 2005.","DOI":"10.1517\/14740338.4.6.987"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kirby D, Ames D. Hyponatraemia and selective serotonin re-uptake inhibitors in elderly patients. Int J Geriatr Psychiatry 16: 484-493, 2001.","DOI":"10.1002\/gps.367"},{"key":"21","unstructured":"21. Ganguli A, Mascarenhas RC, Jamshed N, Tefera E, Veis JH. Hyponatremia: incidence, risk factors, and consequences in the elderly in a home-based primary care program. Clin Nephrol 84: 75-85, 2015."},{"key":"22","unstructured":"22. Cuesta M, Garrahy A, Thompson CJ. SIAD: practical recommendations for diagnosis and management. J Endocrinol Invest 39: 991-1001, 2016."},{"key":"23","unstructured":"23. Siegel AJ. Hyponatremia in psychiatric patients: update on evaluation and management. Harv Rev Psychiatry 16: 13-24, 2008."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Foppiani L. SIADH with severe hyponatremia in an elderly man with herpes zoster infection: a causal or casual association? Intern Med 57: 3393-3398, 2018.","DOI":"10.2169\/internalmedicine.0785-18"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Palmer BF. The role of V2 receptor antagonists in the treatment of hyponatremia. Electrolyte Blood Press 11: 1-8, 2013.","DOI":"10.5049\/EBP.2013.11.1.1"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Pergolizzi JV Jr, Raffa RB, Taylor R Jr, Rodriguez G, Nalamachu S, Langley P. A. Review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain. Pain Pract 13: 239-252, 2013.","DOI":"10.1111\/j.1533-2500.2012.00578.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/12\/58_2059-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T03:39:24Z","timestamp":1560569964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/12\/58_2059-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,15]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2059-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,15]]}}}